EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Interim Adaptation of Proton Therapy in Head and Neck Cancer by Simultaneous Dose and Linear Energy Transfer Escalation

Guillermo Garrido-Hernandez, Kristian Smeland Ytre-Hauge, René M Winter, Signe Danielsen, Mirjam K D Alsaker, Kathrine Røe Redalen, Helge Henjum

International Journal of Radiation Oncology*Biology*Physics · 2025-08 · 122 (5) · 1369-1379

DOI: 10.1016/j.ijrobp.2025.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-08. Verfasst von Guillermo Garrido-Hernandez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: guillermo.g.hernandez@ntnu.no. Hauptthemen laut MEDLINE: Proton Therapy, Head and Neck Neoplasms, Linear Energy Transfer, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Norway, Trond Mohn Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The outcome of proton therapy for head and neck cancer (HNC) varies considerably. We investigated the feasibility of adapting proton therapy plans based on 18F-fluorodeoxyglucose-positron emission tomography-defined biologic tumor volumes (BTVs) reflecting remaining aggressive tumor subvolumes 2 weeks into treatment (interim). Recognizing the potential to improve proton therapy response with increasing linear energy transfer (LET), we simulated a combined dose-LET escalation to the BTVs and compared it to pure dose escalation. In addition, the impact of relative biological effectiveness (RBE) was evaluated by comparing the constant RBE of 1.1 (RBE1.1) with a variable-RBE model. METHODS AND MATERIALS: A semiautomated method was used to segment the BTV from 18F-fluorodeoxyglucose-positron emission tomography-defined for 9 patients with HNC, assuming high standardized uptake value at interim to reflect tumor radioresistance. An in-house Monte Carlo-based recalculation and reoptimization tool simulated proton therapy plans with both constant RBE1.1 and variable-RBE, aimed to deliver 68 Gy (RBE) to high-risk target volumes, 10% dose escalation to the BTV, and a LET boost to the BTV. Dose distributions were prioritized over LET optimization goals. Results were quantified by dose and LET distributions to target volumes and organs at risk, as well as normal tissue complication probabilities (NTCPs) for xerostomia and dysphagia. RESULTS: Dose-LET adapted proton therapy plans achieved 10% dose escalation and mean dose-averaged LET (LETd) increases to the BTV above 1.0 keV/μm, with no significant LET increases to organs at risk. NTCP for xerostomia and dysphagia from dose-LET and dose-only escalation were similar. However, NTCPs increased 6% to 10% when variable-RBE was used instead of the constant RBE1.1. CONCLUSIONS: Our in silico study showed that dose-LET escalation in proton therapy integrating a variable-RBE model may improve proton therapy for patients with HNC. Clinical evaluation of such a biological image-based dose-LET escalation in proton therapy of HNC remains to be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyHead and Neck NeoplasmsLinear Energy TransferRadiotherapy Planning, Computer-AssistedHumansRelative Biological EffectivenessRadiotherapy DosageComputer SimulationMonte Carlo MethodTumor BurdenFluorodeoxyglucose F18RadiopharmaceuticalsPositron-Emission TomographyFeasibility StudiesOrgans at Risk

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: guillermo.g.hernandez@ntnu.no.
  • Department of Physics and Technology, University of Bergen, Bergen, Norway.
  • Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Förderung

  • Research Council of Norway
  • Trond Mohn Foundation

Zitieren

APA

Garrido-Hernandez, G., Ytre-Hauge, K. S., Winter, R. M., Danielsen, S., Alsaker, M. K. D., Redalen, K. R., & Henjum, H. (2025). In Silico Interim Adaptation of Proton Therapy in Head and Neck Cancer by Simultaneous Dose and Linear Energy Transfer Escalation. International Journal of Radiation Oncology*Biology*Physics, 122(5), 1369-1379. https://doi.org/10.1016/j.ijrobp.2025.02.015

Vancouver

Garrido-Hernandez G, Ytre-Hauge KS, Winter RM, Danielsen S, Alsaker MKD, Redalen KR, et al. In Silico Interim Adaptation of Proton Therapy in Head and Neck Cancer by Simultaneous Dose and Linear Energy Transfer Escalation. International Journal of Radiation Oncology*Biology*Physics. 2025;122(5):1369-1379. doi:10.1016/j.ijrobp.2025.02.015

BibTeX
@article{GarridoHernandez2025,
  author = {Garrido-Hernandez, Guillermo and Ytre-Hauge, Kristian Smeland and Winter, René M and Danielsen, Signe and Alsaker, Mirjam K D and Redalen, Kathrine Røe and Henjum, Helge},
  title = {In Silico Interim Adaptation of Proton Therapy in Head and Neck Cancer by Simultaneous Dose and Linear Energy Transfer Escalation},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  volume = {122},
  number = {5},
  pages = {1369--1379},
  doi = {10.1016/j.ijrobp.2025.02.015}
}
Kostenlos starten →